Details

Autor(en) / Beteiligte

• Black-Maier, Eric
• Ren, Xinru
• Steinberg, Benjamin A.
• Green, Cynthia L.
• Barnett, Adam S.
• Rosa, Normita Sta
• Al-Khatib, Sana M.
• Atwater, Brett D.
• Daubert, James P.
• Frazier-Mills, Camille
• Grant, Augustus O.
• Hegland, Donald D.
• Jackson, Kevin P.
• Jackson, Larry R.
• Koontz, Jason I.
• Lewis, Robert K.
• Sun, Albert Y.
• Thomas, Kevin L.
• Bahnson, Tristam D.
• Piccini, Jonathan P.

Titel

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction

Ist Teil von

• Heart rhythm, 2018-05, Vol.15 (5), p.651-657

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Few studies have examined outcomes of catheter ablation for atrial fibrillation (AF) in patients with heart failure (HF) with preserved ejection fraction (HFpEF). The purpose of this study was to compare outcomes of AF ablation in patients with HFpEF vs HF with reduced ejection fraction (HFrEF). We performed a retrospective study of 230 patients with HF who underwent AF ablation, including 97 (42.2%) with HFrEF and 133 (57.8%) with HFpEF. Outcomes included adverse events, symptoms (Mayo AF Symptom Inventory [MAFSI]), New York Heart Association (NYHA) functional class, and freedom from recurrent atrial arrhythmia at 12 months. Overall, 150 of 230 patients had nonparoxysmal AF (62.8% HFpEF vs 63.0% HFrEF). Patients with HFpEF had a smaller mean left atrial diameter (4.4 ± 0.8 cm vs 4.7 ± 0.7 cm; P = .013) and were less likely to be taking a beta-blocker at baseline (72.9% vs 85.6%; P = .022). Median (Q1, Q3) procedure times (233 minutes [192, 290] vs 233.5 minutes [193.0, 297.5]; P = .780) and adverse events such as acute HF (3.8% vs 6.2%; P = .395) were similar between HFpEF and HFrEF patients. Freedom from recurrent atrial arrhythmia was not significantly different in HFpEF vs HFrEF patients (33.9% vs 32.6%; adjusted hazard ratio 1.47; 95% confidence interval 0.72–3.01), with similar improvements in NYHA functional class (−0.32 vs −0.19; P = .135) and MAFSI symptom severity (−0.23 vs −0.09; P = .116) after ablation. Catheter ablation of AF seems to have similar effectiveness in patients with HF, regardless of presence of systolic dysfunction. There were no significant differences in procedural characteristics, arrhythmia-free recurrence, or functional improvements between patients with HFpEF and those with HFrEF.